guidelines:
  1: TNM_Breast_Assessment.v1
test_cases:
- id: case_1
  input:
    1:
      gt0007|Breast cancer stage: 0|local::at0036|Stage 0|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 0|local::at0003|99% Stage 0|


- id: case_2
  input:
    1:
      gt0007|Breast cancer stage: 1|local::at0037|Stage IA|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 1|local::at0004|92% Stage I|

- id: case_3
  input:
    1:
      gt0007|Breast cancer stage: 2|local::at0038|Stage IB|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 1|local::at0004|92% Stage I|

- id: case_4
  input:
    1:
      gt0007|Breast cancer stage: 3|local::at0039|Stage IIA|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 2|local::at0005|82% Stage IIA|

- id: case_5
  input:
    1:
      gt0007|Breast cancer stage: 4|local::at0040|Stage IIB|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 3|local::at0006|65% Stage IIB|

- id: case_6
  input:
    1:
      gt0007|Breast cancer stage: 5|local::at0041|Stage IIIA|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 4|local::at0007|47% Stage IIIA|

- id: case_7
  input:
    1:
      gt0007|Breast cancer stage: 6|local::at0042|Stage IIIB|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 5|local::at0008|44% Stage IIIB|

- id: case_8
  input:
    1:
      gt0007|Breast cancer stage: 7|local::at0043|Stage IIIC|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 6|local::at0009|14-44% Stage IIIc|

- id: case_9
  input:
    1:
      gt0007|Breast cancer stage: 8|local::at0044|Stage IV|
  expected_output:
    1:
      gt0005|5 Year Survival rates: 7|local::at0010|14% Stage IV|

